Comparative Safety of Common Immunosuppressant Therapies in Systemic Lupus Erythematosus: A Target Trial Emulation Study

Study limitation reported by the research below: “Glucocorticoid dose is likely both a confounder and a mediator; full adjustment may obscure true drug-specific effects on infection risk.”